NO955172D0 - Protein-S-delesjonsvarianter med manglende C4BP-bindingsaktivitet, men med APC-kofaktoraktivitet, materialer og terapeutiske metoder - Google Patents

Protein-S-delesjonsvarianter med manglende C4BP-bindingsaktivitet, men med APC-kofaktoraktivitet, materialer og terapeutiske metoder

Info

Publication number
NO955172D0
NO955172D0 NO955172A NO955172A NO955172D0 NO 955172 D0 NO955172 D0 NO 955172D0 NO 955172 A NO955172 A NO 955172A NO 955172 A NO955172 A NO 955172A NO 955172 D0 NO955172 D0 NO 955172D0
Authority
NO
Norway
Prior art keywords
activity
lack
protein
materials
therapeutic methods
Prior art date
Application number
NO955172A
Other languages
English (en)
Other versions
NO955172L (no
Inventor
Rogier Maria Bertina
Bonno Nammen Bouma
Original Assignee
Univ Leiden
Bonno Nammen Bouma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leiden, Bonno Nammen Bouma filed Critical Univ Leiden
Publication of NO955172D0 publication Critical patent/NO955172D0/no
Publication of NO955172L publication Critical patent/NO955172L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO955172A 1993-06-30 1995-12-20 Delesjonsvarianter av protein S med manglende C4BP-bindingsaktivitet, men med APC-kofaktoraktivitet, samt materiale og terapeutiske metoder NO955172L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93201906 1993-06-30
PCT/NL1994/000149 WO1995001433A1 (en) 1993-06-30 1994-06-28 Protein s deletion variants deficient in c4bp binding activity, but having apc cofactor activity, compositions and therapeutic methods

Publications (2)

Publication Number Publication Date
NO955172D0 true NO955172D0 (no) 1995-12-20
NO955172L NO955172L (no) 1996-02-16

Family

ID=8213942

Family Applications (1)

Application Number Title Priority Date Filing Date
NO955172A NO955172L (no) 1993-06-30 1995-12-20 Delesjonsvarianter av protein S med manglende C4BP-bindingsaktivitet, men med APC-kofaktoraktivitet, samt materiale og terapeutiske metoder

Country Status (7)

Country Link
US (2) US5663142A (no)
EP (1) EP0706564A1 (no)
JP (1) JPH08511948A (no)
AU (1) AU6985594A (no)
FI (1) FI956352A (no)
NO (1) NO955172L (no)
WO (1) WO1995001433A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863896A (en) * 1995-11-09 1999-01-26 Immuno Ag Evaluation of substances for altering and for increasing APC response
SE9604378D0 (sv) * 1996-11-27 1996-11-27 Tac Ab Methods and reagents for determining protein S
SE9701228D0 (sv) * 1997-04-03 1997-04-03 Bjoern Dahlbaeck Rekombinanta protein-C-och protein-S-varianter
AU2003277034A1 (en) * 2002-09-30 2004-04-23 Socratech L.L.C. Protein s protects the nervous system from injury
US20070142272A1 (en) * 2003-01-24 2007-06-21 Zlokovic Berislav V Neuroprotective activity of activated protein c independent of its anticoagulant activity
US20070142273A1 (en) * 2003-04-18 2007-06-21 Sherif Daouti Methods and compositions targeting tyrosine kinases for the diagnosis and treatment of osteoarthritis
CA2574598A1 (en) * 2004-07-23 2006-02-09 The University Of Rochester Activated protein c inhibits undesirable effects of plasminogen activator in the brain
EP4174082A1 (en) * 2013-03-15 2023-05-03 GLAdiator Biosciences, Inc. Gla domains as targeting agents
US11981723B2 (en) 2017-09-05 2024-05-14 GLAdiator Biosciences, Inc. Method of targeting exosomes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5321123A (en) * 1991-07-02 1994-06-14 The Scripps Research Institute Protein S polypeptides and anti-peptide antibodies that inhibit protein S binding to C4B binding protein, diagnostic systems and therapeutic methods
US5405946A (en) * 1992-12-02 1995-04-11 The Scripps Research Institute Recombinant protein S variants deficient in C4BP binding activity, compositions and therapeutic methods

Also Published As

Publication number Publication date
US5656484A (en) 1997-08-12
NO955172L (no) 1996-02-16
EP0706564A1 (en) 1996-04-17
US5663142A (en) 1997-09-02
FI956352A0 (fi) 1995-12-29
WO1995001433A1 (en) 1995-01-12
AU6985594A (en) 1995-01-24
JPH08511948A (ja) 1996-12-17
FI956352A (fi) 1996-02-28

Similar Documents

Publication Publication Date Title
NO20071415L (no) OB-fusjonsproteinpreparater og fremgangsmater
DK1028125T3 (da) Dipeptidforbindelser med fungicidaktivitet og deres agronomiske anvendelse
DK0835266T3 (da) Modificerede/kimære superantigener og deres anvendelse
DK0751959T3 (da) Modificerede polypeptider med forøget biologisk aktivitet
DK1491193T3 (da) Terapeutiske kombinationer omfattende amlodipin og atorvastatin
NO942193D0 (no) Metallocener og fremgangsmåte til deres fremstilling og bruk
IS5928A (is) Aðferðir og samsetningar til að hindra lyfjaþol
DK0721457T3 (da) 2',5'-Oligoadenylat-2',3'-cyclophosphater og 2',5'-oligo-adenylater med antipapillomavirusaktivitet
NO955172D0 (no) Protein-S-delesjonsvarianter med manglende C4BP-bindingsaktivitet, men med APC-kofaktoraktivitet, materialer og terapeutiske metoder
DE58902290D1 (de) Sauerstoffabsorptionsmittel und verwendung desselben.
DK229189A (da) Modificerede blokpolymerisater, deres fremstilling og anvendelse
NO982181D0 (no) Type IX collagen og chimerer
NO326826B1 (no) Alfa-aminosyreamider, fremstilling og terapeutisk anvendelse derav
DK393489A (da) Benzodiazepinforbindelser og fremgangsmaade til deres fremstilling
DK221389A (da) Fibronectin-bindende protein og fremgangsmaade til fremstilling deraf
DK0983300T3 (da) BPC-peptidsalte med organbeskyttende aktivitet, proces til fremstilling af disse og terapeutisk anvendelse heraf
DK584389D0 (da) Kombinationsherbicid og dets anvendelse
DK634089A (da) Polyhydroxybenzyloxypropanolaminer og deres anvendelse
NO990303D0 (no) Lipidbindende proteiner og deres terapeutiske og diagnostiske anvendelse
DE59705015D1 (de) Stabilisatormischungen und ihre Verwendung in Polycarbonaten
NO892190D0 (no) Kompositt-materialer og deres anvendelse.
DK131189A (da) Fremgangsmaade og middel til ophthalmisk anaestesi
NO970165D0 (no) Kortikotropin frigivningsfaktor-bindingsprotein inhibitorer og deres anvendelse
DK355289A (da) 2,2-dihalogencyclopropyl-hydroxy-ethyltriazoler, fremgangsmaader og mellemprodukter til deres fremstilling samt deres anvendelse
NO910090L (no) Vevstransplantat-sammensetning og metode.